Skip to content
Screener

Reported February 5, 2026 · Before market open

Revenue$283.4MBeat by $1.2M
EPS$1.14Miss by $0.02
Revenue estimate$282.2M
EPS estimate$1.16

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$329.1M
EPS estimate$1.06

Financials

Q3 2026

Income statement

See full
Revenue$283.4M-2.4%
Gross profit$157.4M-2.3%
Operating income$82.5M-10.3%
Net income$46.7M-23.5%
EPS (diluted)$0.97-20.5%

Balance sheet

See full
Cash & equivalents$62.4M+22.6%
Total debt$1.1B+4.4%
Total equity$1.8B+2.3%
Total assets$3.5B+5.0%

Cash flow

See full
Operating cash flow$78.3M+20.3%
CapEx$3.0M+93.4%
Free cash flow$75.3M+18.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$2.97B-23.1%
Enterprise value$3.99B-17.7%
P/E15.9×-2.1×
P/S2.7×-0.8×

Profitability

See full
Gross margin56.1%+1.0pp
Operating margin29.2%-0.3pp
Net margin16.9%-2.2pp
FCF margin24.2%+2.0pp

Returns & leverage

See full
Return on equity10.3%-2.3pp
Debt / equity0.6×0.0×
Current ratio3.1×-0.6×

Segments

By product

See full
Gastrointestinal$69.5M+0.7%
Women's Health$57.8M-0.6%
Eye & Ear Care$38.6M-15.5%
Dermatologicals$29.6M-3.3%
Oral Care$26.6M+15.2%

By segment

See full
North American OTC Healthcare$235.7M-1.4%
International OTC Healthcare$47.7M-7.1%

FAQ

When did Prestige Consumer Healthcare report Q3 2026 earnings?
Prestige Consumer Healthcare (PBH) reported Q3 2026 earnings on February 5, 2026 before market open.
What were Prestige Consumer Healthcare's Q3 2026 revenue and EPS?
Prestige Consumer Healthcare reported revenue of $283.4M and eps of $1.14 for Q3 2026.
Did Prestige Consumer Healthcare beat estimates in Q3 2026?
Revenue beat the consensus estimate of $282.2M by $1.2M. EPS missed the consensus estimate of $1.16 by $0.02.
How did Prestige Consumer Healthcare's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.4% from $290.3M a year earlier and eps declined 6.6% from $1.22.
Where can I find Prestige Consumer Healthcare's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001295947-26-000006) and the 10-Q periodic report (0001295947-26-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.